Quantcast
Channel: The Fecal Transplant Foundation » News
Browsing all 10 articles
Browse latest View live

C. diff. Gulf Coast Collaborative

  I’d like to acknowledge the important work being done by the C. difficile Gulf Coast Collaborative.  I was honored to be a guest speaker in Houston at the Texas Medical Center on Saturday, December...

View Article



OpenBiome

I would like to announce what will be an ongoing relationship between The Foundation, and Open Biome, a brilliant and compassionate group of scientists from MIT, Harvard, and Princeton, who have formed...

View Article

Another Donor Stool Bank

Taymount Clinic located in the U.K., is selling tested donor stool to physicians and hospitals in the U.K. and Europe.

View Article

Gut Eco System Restoration by FMT

View Article

Rebiotix Completes Enrollment for Trial Using Microbiota Restoration Therapy...

This is the first multi-center study of a next-generation fecal transplant. The PUNCH™ CD study, sponsored by Rebiotix Inc., has completed enrollment. This study represents Rebiotix’s progress toward...

View Article


Taymount Clinic in UK Provides FMT and Donor Bank for UK and Europe

The Taymount Clinic was founded by Glenn Taylor and Enid Learmount (now Enid Taylor ND) in 2003 as a small private clinic specializing in digestive health. Initially the clinic focused on Naturopathic...

View Article

All set for the Gut Microbiota for Health Summit 2014

After the success of the first two editions (held in Evian and Madrid in 2012 and 2013 respectively),experts from all over the world are getting ready to head to Miami (USA) for the 2014 edition of the...

View Article

Microbiome Therapeutics Reports Positive Top-Line Results from Clinical Trial...

Statistically Significant Positive Results from First Double-Blind, Randomized Clinical Trial of a Microbiome Modulator for Diabetes– –NM504 Significantly Improved Glucose Control in Patients with...

View Article


Updated Information About Rebiotix Punch CD 2 Trial

PUNCH™ CD 2 Study: A Clinical Trial For The Treatment Of Recurrent Clostridium difficile Infection Is Currently Enrolling Patients     The PUNCH™ CD 2 study, sponsored by Rebiotix Inc., is open for...

View Article


Article 0

Here is a story about two individuals, Michael Hurst and Sandy Bishop, who both experienced positive impacts from fecal transplants. While we do not endorse do it yourself methods and recognize that...

View Article
Browsing all 10 articles
Browse latest View live




Latest Images